$-0.21 EPS Expected for Aemetis Inc (AMTX)

November 4, 2017 – By Louis Casey

Wall Street await Aemetis Inc (NASDAQ:AMTX) to release earnings on November, 13. Analysts forecast earnings per share of $-0.21, exactly $0.00 or 0.00 % from 2014’s $-0.21 EPS. After posting $-0.30 EPS for the previous quarter, Aemetis Inc’s analysts now forecast -30.00 % EPS growth. The stock decreased 3.66% or $0.03 on November 3, reaching $0.79. About 26,384 shares traded. Aemetis Inc (NASDAQ:AMTX) has declined 50.79% since November 4, 2016 and is downtrending. It has underperformed by 67.49% the S&P500.

Aemetis, Inc. is an international renewable fuels and biochemicals company. The company has market cap of $15.66 million. The Firm is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum products by conversion of first-generation ethanol and biodiesel plants into biorefineries. It currently has negative earnings. The Company’s divisions include North America and India.

More news for Aemetis Inc (NASDAQ:AMTX) were recently published by: Finance.Yahoo.com, which released: “CORRECTING and REPLACING Edeniq Brings Fraud and Other Cross-Claims Against …” on March 23, 2017. Seekingalpha.com‘s article titled: “Aemetis – Changes Bring More Potential Upside” and published on May 26, 2016 is yet another important article.